Sort
17,288 grants matching “multiple sclerosis”
Synergy between T cells and Complement in EAE
$237,137Feng Lin · Case Western Reserve University · R01 · FY2008 · NS
Synergy between T cells and Complement in EAE
$237,137Feng Lin · Case Western Reserve University · R01 · FY2009 · NS
Novel Riluzole Derivatives for Alzheimer's Disease
$237,040Jeffrey D Erickson · Lsu Health Sciences Center · R21 · FY2020 · NS
Fluorinated 4-Aminopyridines for Therapy and Diagnosis of Multiple Sclerosis
$237,000Brian J Popko · University Of Chicago · R21 · FY2014 · NS
Pathogenesis of Theiler's virus-induced demyelinating disease
$237,000Raymond Philip Roos · University Of Chicago · R21 · FY2016 · NS
Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes
$237,000Stephen D Miller · Northwestern University At Chicago · R21 · FY2020 · AI
Cross species molecular analysis of glial and endothelial blood-brain barriers
$237,000Richard Daneman · University Of California, San Diego · R21 · FY2024 · NS
Combining Immune Tolerance and Myelin Repair Therapy in T cell-driven MS Models
$237,000Stephen D Miller · Northwestern University At Chicago · R21 · FY2019 · AI
Targeting ALS-linked FUS with allele-specific antisense oligonucleotides
$236,911Luis Alberto Williams · Q-State Biosciences, Inc. · R43 · FY2020 · NS
Quality Improvement and Practice Based Research in Neurology Using the EMR
$236,877Demetrius Michael Maraganore · Endeavor Health Clinical Operations · R01 · FY2017 · HS
Disease Modifying Potential of Glatiramer Acetate in Huntington's disease
$236,875Elizabeth A Thomas · Scripps Research Institute, The · R21 · FY2015 · NS
Identifying a viral cause of Multiple Sclerosis
$236,870Evanston Northwestern Healthcare · R01 · FY2003 · NS
The eye as a window into sickle cell disease morbidity
$236,855Jing Jin · Nemours Children'S Hospital, Delaware · P20 · FY2023 · GM
The eye as a window into sickle cell disease morbidity
$236,855Jing Jin · Nemours Children'S Hospital, Delaware · P20 · FY2022 · GM
Dimethyl Fumarate In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
$236,840Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · R21 · FY2017 · AR
Nitroxides as Protectors Against Oxidative Stress
$236,812James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
$236,808Iain Leslie Campbell · University Of Sydney · R01 · FY2007 · NS
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
$236,808Iain Leslie Campbell · University Of Sydney · R01 · FY2008 · NS
Viral impact on autoimmune T cells
$236,718Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
TRAINING PROGRAM IN THE NEUROSCIENCES
$236,605New York University School Of Medicine · T32 · FY2004 · DC
Clinical Translation of a Neuron Protective Recombinant Human Antibody
$236,550Moses Rodriguez · Mayo Clinic Rochester · R21 · FY2011 · NS
BASIS FOR VISUAL IMPAIRMENT IN MULTIPLE SCLEROSIS: BEYOND RETINAL GANGLION CELLS
$236,550The Leland Stanford Junior University · · FY2021 · Defense Health Agency
Neurologic Clinical Epidemiology Training Program
$236,523Laura J Balcer · University Of Pennsylvania · T32 · FY2010 · NS
Mechanisms of immune homeostasis and regulation of intraocular inflammation
$236,392Charles E Egwuagu · National Eye Institute · ZIA · FY2013 · EY
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
$236,304Michael Pluth · University Of Oregon · R00 · FY2013 · GM